Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Eur J Endocrinol. 2013 Nov 29;170(1):151–160. doi: 10.1530/EJE-13-0740

Table 2.

Clinical and mutational summaries of groups of familial and sporadic CNC.

n Age Sex (M/F) PPNAD Myxoma Lentiginosis Other
tumors
PRKAR1A
mutation
PRKAR1A
deletion
PDE11A
mutation
Familial CNC 19 37±18 8/11 10 11 16 8 14 1 0
Sporadic CNC 27 40±17 7/20 18 18 20 7 19 0 1